Regulation of GPCRs By RGS21 (G431704)

Target Name: RGS21

NCBI ID: G431704

RGS21

Regulation of GPCRs By RGS21

G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. They are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPCRs are also known as G protein-coupled receptors, GPCR, or GR. The regulator of G protein signaling 21 (RGS21) is a protein that is involved in the regulation of GPCRs. It is a member of the family of GPCR regulators, which includes proteins such as Grp, PIK3, and ZAP.

RGS21 is a protein that is expressed in many different tissues and organs, including the brain, heart, and kidneys. It is primarily localized to the endoplasmic reticulum (ER), which is the body's primary protein synthesis and loading facility. RGS21 is known to play a role in the regulation of GPCRs, which are involved in a wide range of physiological processes.

GPCRs are a family of transmembrane proteins that are involved in a wide range of cellular signaling processes. They are characterized by the presence of a catalytic active center, a transmembrane region, and an extracellular portion that is involved in cell-cell interactions. GPCRs are involved in the regulation of a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. They are also involved in the regulation of cell growth, differentiation, and survival.

RGS21 is a protein that is involved in the regulation of GPCRs. It is a member of the family of GPCR regulators, which includes proteins such as Grp, PIK3, and ZAP. These proteins are involved in the regulation of GPCRs by binding to specific GPCR receptors. RGS21 is known to play a role in the regulation of the GPCR receptor, GRP-尾2, which is involved in the regulation of a wide range of physiological processes.

GRP-尾2 is a GPCR that is involved in the regulation of a wide range of physiological processes, including blood pressure, muscle contractions, and the regulation of pain. It is characterized by the presence of a catalytic active site, a transmembrane region, and an extracellular portion that is involved in cell-cell interactions. GRP-尾2 is regulated by RGS21, which is known to bind to the active site of GRP-尾2 and enhance its catalytic activity.

RGS21 is also involved in the regulation of the GPCR receptor, GRP-伪2, which is involved in the regulation of a wide range of physiological processes, including the regulation of blood vessel diameter and the regulation of pain. GRP-伪2 is characterized by the presence of a catalytic active site, a transmembrane region, and an extracellular portion that is involved in cell-cell interactions. RGS21 is known to bind to the active site of GRP-伪2 and enhance its catalytic activity.

In conclusion, RGS21 is a protein that is involved in the regulation of GPCRs. It is a member of the family of GPCR regulators and is known to play a role in the regulation of the GPCR receptor, GRP-尾2. RGS21 is also involved in the regulation of the GPCR receptor, GRP-伪2, which is involved in the regulation of a wide range of physiological processes. Further research is needed to fully understand the role of RGS21 in the regulation of GPCRs.

Protein Name: Regulator Of G Protein Signaling 21

Functions: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form

The "RGS21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RGS21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets